SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-038922
Filing Date
2018-06-07
Accepted
2018-06-07 16:35:29
Documents
7
Period of Report
2018-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-13864_38k.htm 8-K 30311
2 EX-1.1 a18-13864_3ex1d1.htm EX-1.1 231595
3 EX-5.1 a18-13864_3ex5d1.htm EX-5.1 13697
4 EX-99.1 a18-13864_3ex99d1.htm EX-99.1 9355
5 EX-99.2 a18-13864_3ex99d2.htm EX-99.2 11199
6 GRAPHIC g138643kki001.gif GRAPHIC 2445
7 GRAPHIC g138643moi001.jpg GRAPHIC 3133
  Complete submission text file 0001104659-18-038922.txt   305230
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 18886894
SIC: 2834 Pharmaceutical Preparations